About Atreca
Atreca is a company based in San Carlos (United States) founded in 2010.. Atreca has raised $224.4 million across 9 funding rounds from investors including Gates Foundation, GSK and Tekla Capital Management. The company has 134 employees as of December 31, 2021. Atreca operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter San Carlos, United States
- Employees 134 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Atreca, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$224.4 M (USD)
in 9 rounds
-
Latest Funding Round
$125 M (USD), Series C
Sep 12, 2018
-
Investors
Gates Foundation
& 9 more
-
Employee Count
134
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Atreca
Atreca has successfully raised a total of $224.4M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $125 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series C — $125.0M
-
First Round
First Round
(11 Nov 2011)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2018 | Amount | Series C - Atreca | Valuation | Aisling Capital , EcoR1 | |
| Aug, 2017 | Amount | Series B - Atreca | Valuation | Wellington |
|
| Oct, 2015 | Amount | Series A - Atreca | Valuation | Gates Foundation , GSK |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Atreca
Atreca has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Gates Foundation, GSK and Tekla Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided by Samsara BioCapital in California.
|
Founded Year | Domain | Location | |
|
Biotech startups are funded by this venture capital firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Atreca
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Atreca
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Atreca Comparisons
Competitors of Atreca
Atreca operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Atreca
Frequently Asked Questions about Atreca
When was Atreca founded?
Atreca was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is Atreca located?
Atreca is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
Is Atreca a funded company?
Atreca is a funded company, having raised a total of $224.4M across 9 funding rounds to date. The company's 1st funding round was a Series A of $57.26M, raised on Nov 11, 2011.
How many employees does Atreca have?
As of Dec 31, 2021, the latest employee count at Atreca is 134.
What does Atreca do?
Developer of antibody therapeutics for human anti-cancer immune responses. Atrecas proprietary Immune Repertoire Capture technology profiles a patients immune response at the single-cell level, enabling the identification and generation of functional human antibodies and TCRs without prior knowledge of antigen. Its technology can be used for the discovery and development of antibody-based therapeutics and for identifying the critical targets of effective immune responses. It is applying its technology to generate and develop a novel class of cancer immunotherapies including therapeutics that optimize anti-tumor immune responses in synergy with checkpoint inhibitors and immune activators.
Who are the top competitors of Atreca?
Atreca's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Who are Atreca's investors?
Atreca has 10 investors. Key investors include Gates Foundation, GSK, Tekla Capital Management, Wellington, and Aisling Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.